10 September 2023, 9:45am - 11:45am - Platform 1: Modern in vitro genetox screening and data modeling. “In Vitro-In Vivo Extrapolation (IVIVE) of Genetic Toxicity New Approach Methodology (NAM) Data: A HESI-GTTC Case Study” presented by Dr. Alexandra Long (Health Canada).
12 September 2023, 1:15 - 3:15pm - Platform 5:Don’t shoot the messenger: Mutant fraction and mutation frequency quantitation is biased by coverage depth in error-corrected sequencing studies, presented by: Meagan Myers, National Center for Toxicological Research/US FDA
13 September 2023, 1:15 - 3:15pm - Symposium 14: Ongoing validations of TGR tech transfer and bridging studies from TGR to ecNGS. Highlights GTTC’s ecNGS working group reconstruction experiment.
12 September 2023 - Full-day Session - Evaluating genotoxic potential of genome editing for therapeutic use. Presentation titled “Induce-Seq followed by Duplex-Seq for identification and confirmation of CRISPR-Cas9 off-targets- A HESI CT-TRACS supported project”.
Privacy & Cookies Policy
Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.
Any cookies that may not be particularly necessary for the website to function and is used specifically to collect user personal data via analytics, ads, other embedded contents are termed as non-necessary cookies. It is mandatory to procure user consent prior to running these cookies on your website.